Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions

Critical Reviews in Food Science and Nutrition

Volumn 43, Issue 1, 2003, Pages 89-143

  Higdon, Jane V ^a   Frei, Balz ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

8 hydroxydeoxyguanosine; 8 OHdG; Cancer; Cardiovascular disease; Epidemiology; F 2 isoprostanes; Flavanol; FRAP; LDL oxidation; ORAC; Osteoporosis; Plasma antioxidant capacity; TEAC; Theaflavin; Thearubigin

Indexed keywords

8-HYDROXYDEOXYGUANOSINE; 8-OHDG; CARDIOVASCULAR DISEASES; F2-ISOPROSTANES; FLAVANOLS; LDL OXIDATION; OSTEOPOROSIS; PLASMA ANTIOXIDANT CAPACITY; THEAFLAVINS; THEARUBIGIN;

ANGIOGRAPHY; ANTIOXIDANTS; BIOMARKERS; DIMERS; DNA; ENZYMES; EPIDEMIOLOGY; HEALTH; HEALTH RISKS; METABOLISM; OXIDATION; PROTEINS; RADIOGRAPHY; TUMORS;

PHENOLS;

ANIMALIA; LETHRINIDAE;

ANTIOXIDANT; BIOLOGICAL MARKER; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FLAVONOID; PHENOL DERIVATIVE; POLYMER; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL; BIOAVAILABILITY; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC DISEASE; HUMAN; METABOLISM; MORTALITY; NEOPLASM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; TEA;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CATECHIN; CHRONIC DISEASE; FLAVONOIDS; FREE RADICAL SCAVENGERS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; PHENOLS; POLYMERS; REACTIVE OXYGEN SPECIES; TEA;

EID: 0038121053     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408690390826464     Document Type: Review

References (301)

1. Graham H. N., Green tea composition, consumption, and polyphenol chemistry, Prev. Med., 1992; 21:334-350.
2. Hollman P. C., Feskens E. J., and Katan M. B., Tea flavonols in cardiovascular disease and cancer epidemiology, Proc. Soc. Exp. Biol. Med., 1999; 220:198-202.
3. Katiyar S. K., and Elemets C. A., Green tea polyphenolic antioxidants and skin photoprotection (review), Int. J. Oncol., 2001; 18:1307-1313.
4. Proniuk S., Liederer B. M., and Blanchard J., Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention, J. Pharm. Sci., 2002; 91:111-116.
5. Wiseman S. A., Balentine D. A., and Frei B., Antioxidants in tea, Crit. Rev. Food Sci. Nutr., 1997; 37:705-718.
6. Hirvonen T., Virtamo J., Korhonen P., Albanes D., and Pietinen P., Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers, Stroke, 2000; 31:2301-2306.
7. Klatsky A. L., Armstrong M. A., and Friedman G. D., Coffee, tea, and mortality, Ann. Epidemiol., 1993; 3:375-381.
8. Rimm E. B., Katan M. B., Ascherio A., Stampfer M. J., and Willett W. C., Relation between intake of flavonoids and risk for coronary heart disease in male health professionals, Ann. Intern. Med., 1996; 125:384-389.
9. Stensvold I., Tverdal A., Solvoll K., and Foss O. P., Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality, Prev. Med., 1992; 21:546-553.
10. Woodward M., and Tunstall-Pedoe H., Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality, J. Epidemiol. Community Health, 1999; 53:481-487.
11. Yochum L., Kushi L. H., Meyer K., and Folsom A. R., Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women, Am. J. Epidemiol., 1999; 149:943-949.
12. Hertog M. G., Feskens E. J., Hollman P. C., Katan M. B., and Kromhout D., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study, Lancet, 1993; 342:1007-1011.
13. Nakachi K., Matsuyama S., Miyake S., Suganuma M., and Imai K., Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention, Biofactors, 2000; 13:49-54.
14. Hertog M. G., Sweetnam P. M., Fehily A. M., Elwood P. C., and Kromhout D., Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study, Am. J. Clin. Nutr., 1997; 65:1489-1494.
15. Geleijnse J. M., Launer L. J., Hofman A., Pols H. A., and Witteman J. C., Tea flavonoids may protect against atherosclerosis: the Rotterdam Study, Arch. Intern. Med, 1999; 159:2170-2174.
16. Sato Y., Nakatsuka H., Watanabe T., et al., Possible contribution of green tea drinking habits to the prevention of stroke, Tohoku J. Exp. Med., 1989; 157:337-343.
17. Keli S. O., Hertog M. G., Feskens E. J., and Kromhout D., Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study, Arch. Intern. Med, 1996; 156:637-642.
18. Sesso H. D., Gaziano J. M., Buring J. E., and Hennekens C. H., Coffee and tea intake and the risk of myocardial infarction, Am. J. Epidemiol., 1999; 149:162-167.
19. Coffee drinking and acute myocardial infarction. Report from the Boston Collaborative Drug Surveillance Program, Lancet, 1972; 2:1278-1281.
20. Gramenzi A., Gentile A., Fasoli M., Negri E., Parazzini F., and La Vecchia C., Association between certain foods and risk of acute myocardial infarction in women, Br. Med. J., 1990; 300:771-773.
21. Jick H., Miettinen O. S., Neff R. K., Shapiro S., Heinonen O. P., and Slone D., Coffee and myocardial infarction, N. Engl. J. Med., 1973; 289:63-67.
22. Rosenberg L., Miller D. R., Helmrich S. P., et al., Breast cancer and the consumption of coffee, Am. J. Epidemiol., 1985; 122:391-399.
23. Rosenberg L., Palmer J. R., Kelly J. P., Kaufman D. W., and Shapiro S., Coffee drinking and nonfatal myocardial infarction in men under 55 years of age, Am. J. Epidemiol., 1988; 128:570-578.
24. Sasazuki S., Kodama H., Yoshimasu K., et al., Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women, Ann. Epidemiol., 2000; 10:401-408.
25. Riemersma R. A., Rice-Evans C. A., Tyrrell R. M., Clifford M. N., and Lean M. E., Tea flavonoids and cardiovascular health, Q.J.M., 2001; 94:277-282.
26. Hirvonen T., Pietinen P., Virtanen M., et al., Intake of flavonols and flavones and risk of coronary heart disease in male smokers, Epidemiology, 2001; 12:62-67.
27. Knekt P., Jarvinen R., Reunanen A., and Maatela J., Flavonoid intake and coronary mortality in Finland: a cohort study, Br. Med. J., 1996; 312:478-481.
28. Hertog M. G., Feskens E. J., and Kromhout D., Antioxidant flavonols and coronary heart disease risk, Lancet, 1997; 349:699.
29. Arts I. C., Hollman P. C., Feskens E. J., Bueno de Mesquita H. B., and Kromhout D., Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study, Am. J. Clin. Nutr., 2001; 74:227-232.
30. Peters U., Poole C., and Arab L., Does tea affect cardiovascular disease? A meta-analysis, Am. J. Epidemiol., 2001; 154:495-503.
31. Duffy S. J., Keaney J. F., Jr., Holbrook M., et al., Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease, Circulation, 2001; 104:151-156.
32. Hodgson J. M., Puddey I. B., Burke V., Watts G. F., and Beilin L. J., Regular ingestion of black tea improves brachial artery vasodilator function, Clin. Sci., 2002; 102:195-201.
33. Ross R., Atherosclerosis - an inflammatory disease, N. Engl. J. Med., 1999; 340:115-126.
34. Gokce N., Keaney J. F., Jr., Frei B., et al., Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease, Circulation, 1999; 99:3234-3240.
35. Huang A., Vita J. A., Venema R. C., and Keaney J. F., Jr., Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin, J. Biol. Chem., 2000; 275:17399-17406.
36. Zheng W., Doyle T. J., Kushi L. H., Sellers T. A., Hong C. P., and Folsom A. R., Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women, Am. J. Epidemiol., 1996; 144:175-182.
37. Kinlen L. J., Willows A. N., Goldblatt P., and Yudkin J., Tea consumption and cancer, Br. J. Cancer, 1988; 58:397-401.
38. Blot W. J., McLaughlin J. K., and Chow W. H., Cancer rates among drinkers of black tea, Crit. Rev. Food Sci. Nutr., 1997; 37:739-760.
39. Hertog M. G., Feskens E. J., Hollman P. C., Katan M. B., and Kromhout D., Dietary flavonoids and cancer risk in the Zutphen Elderly Study, Nutr. Cancer, 1994; 22:175-184.
40. Imai K., Suga K., and Nakachi K., Cancer-preventive effects of drinking green tea among a Japanese population, Prev. Med., 1997; 26:769-775.
41. Van Rensburg S. J., Bradshaw E. S., Bradshaw D., and Rose E. F., Oesophageal cancer in Zulu men, South Africa: a case control study, Br. J. Cancer, 1985; 51:399-405.
42. Notani P. N., and Jayant K., Role of diet in upper aerodigestive tract cancers, Nutr. Cancer, 1987; 10:103-113.
43. Hu J., Nyren O., Wolk A., et al., Risk factors for oesophageal cancer in northeast China, Int. J. Cancer, 1994; 57:38-46.
44. Gao Y. T., McLaughlin J. K., Blot W. J., Ji B. T., Dai Q., and Fraumeni J. F., Jr., Reduced risk of esophageal cancer associated with green tea consumption, J. Natl. Cancer Inst., 1994; 86:855-858.
45. Castellsague X., Munoz N., De Stefani E., Victora C. G., Castelletto R., and Rolon P. A., Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America, Int. J. Cancer, 2000; 88:658-664.
46. Galanis D. J., Kolonel L. N., Lee J., and Nomura A., Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study, Int. J. Epidemiol., 1998; 27:173-180.
47. Goldbohm R. A., Hertog M. G., Brants H. A., van Poppel G., and van den Brandt P. A., Consumption of black tea and cancer risk: a prospective cohort study, J. Natl. Cancer Inst., 1996; 88:93-100.
48. Heilbrun L. K., Nomura A., and Stemmermann G. N., Black tea consumption and cancer risk: a prospective study, Br. J. Cancer, 1986; 54:677-683.
49. Tsubono Y., Nishino Y., Komatsu S., et al., Green tea and the risk of gastric cancer in Japan, N. Engl. J. Med., 2001; 344:632-636.
50. Kono S., Ikeda M., Tokudome S., and Kuratsune M., A case control study of gastric cancer and diet in northern Kyushu, Japan, Jpn. J. Cancer Res., 1988; 79:1067-1074.
51. Setiawan V. W., Zhang Z. F., Yu G. P., et al., Protective effect of green tea on the risks of chronic gastritis and stomach cancer, Int. J. Cancer, 2001; 92:600-604.
52. Yu G. P., and Hsieh C. C., Risk factors for stomach cancer: a population-based case control study in Shanghai, Cancer Causes Control, 1991; 2:169-174.
53. Yu G. P., Hsieh C. C., Wang L. Y., Yu S. Z., Li X. L., and Jin T. H., Green-tea consumption and risk of stomach cancer: a population-based case control study in Shanghai, China, Cancer Causes Control, 1995; 6:532-538.
54. Chow W. H., Swanson C. A., Lissowska J., et al., Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland, Int. J. Cancer, 1999; 81:871-876.
55. Hansson L. E., Nyren O., Bergstrom R., et al., Diet and risk of gastric cancer. A population-based case control study in Sweden, Int. J. Cancer, 1993; 55:181-189.
56. Memik F., Nak S. G., Gulten M., and Ozturk M., Gastric carcinoma in northwestern Turkey: epidemiologic characteristics, J. Environ. Pathol. Toxicol. Oncol., 1992; 11:335-338.
57. Higginson J., Etiological factors in gastrointestinal cancer in man, J. Natl. Cancer Inst., 1966; 37:527-545.
58. Tajima K. and Tominaga S., Dietary habits and gastrointestinal cancers: a comparative case control study of stomach and large intestinal cancers in Nagoya, Japan, Jpn. J. Cancer Res., 1985; 76:705-716.
59. Trichopoulos D., Ouranos G., Day N. E., et al., Diet and cancer of the stomach: a case control study in Greece, Int. J. Cancer, 1985; 36:291-297.
60. Lee H. H., Wu H. Y., Chuang Y. C., et al., Epidemiologic characteristics and multiple risk factors of stomach cancer in Taiwan, Anticancer Res., 1990; 10:875-881.
61. Demirer T., Icli F., Uzunalimoglu O., and Kucuk O., Diet and stomach cancer incidence. A case control study in Turkey, Cancer, 1990; 65:2344-2348.
62. La Vecchia C., Negri E., Franceschi S., D'Avanzo B., and Boyle P., Tea consumption and cancer risk, Nutr. Cancer, 1992; 17:27-31.
63. Hoshiyama Y., and Sasaba T., A case control study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption in Saitama Prefecture, Japan, Cancer Causes Control, 1992; 3:441-448.
64. Agudo A., Gonzalez C. A., Marcos G., et al., Consumption of alcohol, coffee, and tobacco, and gastric cancer in Spain, Cancer Causes Control, 1992; 3:137-143.
65. Inoue M., Tajima K., Hirose K., Kuroishi T., Gao C. M., and Kitoh T., Life-style and subsite of gastric cancer - joint effect of smoking and drinking habits, Int. J. Cancer, 1994; 56:494-499.
66. Ji B. T., Chow W. H., Yang G., et al., The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China, Cancer, 1996; 77:2449-2457.
67. Inoue M., Tajima K., Hirose K., et al., Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan, Cancer Causes Control, 1998; 9:209-216.
68. Hartman T. J., Tangrea J. A., Pietinen P., et al., Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men, Nutr. Cancer, 1998; 31:41-48.
69. Kato I., Tominaga S., Matsuura A., Yoshii Y., Shirai M., and Kobayashi S., A comparative case control study of colorectal cancer and adenoma, Jpn. J. Cancer Res., 1990; 81:1101-1108.
70. Olsen J. and Kronborg O., Coffee, tobacco and alcohol as risk factors for cancer and adenoma of the large intestine, Int. J. Epidemiol., 1993; 22:398-402.
71. Baron J. A., Gerhardsson de Verdier M., and Ekbom A., Coffee, tea, tobacco, and cancer of the large bowel, Cancer Epidemiol. Biomarkers. Prev., 1994; 3:565-570.
72. Ji B. T., Chow W. H., Hsing A. W., et al., Green tea consumption and the risk of pancreatic and colorectal cancers, Int. J. Cancer, 1997; 70:255-258.
73. Tavani A., Pregnolato A., La Vecchia C., Negri E., Talamini R., and Franceschi S., Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3,530 cases and 7,057 controls, Int. J. Cancer, 1997; 73:193-197.
74. Munoz S. E., Navarro A., Lantieri M. J., et al., Alcohol, methylxanthine-containing beverages, and colorectal cancer in Cordoba, Argentina, Eur. J. Cancer Prev., 1998; 7:207-213.
75. Shibata A., Mack T. M., Paganini-Hill A., Ross R. K., and Henderson B. E., A prospective study of pancreatic cancer in the elderly, Int. J. Cancer, 1994; 58:46-49.
76. Whittemore A. S., Paffenbarger R. S., Jr., Anderson K., and Halpern J., Early precursors of pancreatic cancer in college men, J. Chronic Dis., 1983; 36:251-256.
77. Hiatt R. A., Klatsky A. L., and Armstrong M. A., Pancreatic cancer, blood glucose and beverage consumption, Int. J. Cancer, 1988; 41:794-797.
78. Harnack L. J., Anderson K. E., Zheng W., Folsom A. R., Sellers T. A., and Kushi L. H., Smoking, alcohol, coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women's Health Study, Cancer Epidemiol. Biomarkers. Prev., 1997; 6:1081-1086.
79. Michaud D. S., Giovannucci E., Willett W. C., Colditz G. A., and Fuchs C. S., Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts, Cancer Epidemiol. Biomarkers. Prev., 2001; 10:429-437.
80. MacMahon B., Yen S., Trichopoulos D., Warren K., and Nardi G., Coffee and cancer of the pancreas, N. Engl. J. Med., 1981; 304:630-633.
81. Mack T. M., Yu M. C., Hanisch R., and Henderson B. E., Pancreas cancer and smoking, beverage consumption, and past medical history, J. Natl. Cancer Inst., 1986; 76:49-60.
82. Raymond L., Infante F., Tuyns A. J., Voirol M., and Lowenfels A. B., Diet and cancer of the pancreas, Gastroenterol. Clin. Biol., 1987; 11:488-492.
83. Cuzick J., and Babiker A. G., Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease, Int. J. Cancer, 1989; 43:415-421.
84. Mizuno S., Watanabe S., Nakamura K., et al., A multi-institute case control study on the risk factors of developing pancreatic cancer, Jpn. J. Clin. Oncol., 1992; 22:286-291.
85. Bueno de Mesquita H. B., Maisonneuve P., Moerman C. J., Runia S., and Boyle P., Lifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case control study in The Netherlands, Int. J. Cancer, 1992; 50:514-522.
86. Goto R., Masuoka H., Yoshida K., Mori M., and Miyake H., A case control study of cancer of the pancreas, Gan No Rinsho, 1990; Spec No:344-350.
87. Kinlen L. J. and McPherson K., Pancreas cancer and coffee and tea consumption: a case control study, Br. J. Cancer, 1984; 49:93-96.
88. Mori M., Hariharan M., Anandakumar M., et al., A case control study on risk factors for pancreatic diseases in Kerala, India, Hepatogastroenterology, 1999; 46:25-30.
89. Zatonski W. A., Boyle P., Przewozniak K., Maisonneuve P., Drosik K., and Walker A. M., Cigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: a case control study from Opole, Poland, Int. J. Cancer, 1993; 53:601-607.
90. Knekt P., Jarvinen R., Seppanen R., et al., Dietary flavonoids and the risk of lung cancer and other malignant neoplasms, Am. J. Epidemiol., 1997; 146:223-230.
91. Arts I. C., Hollman P. C., Bueno De Mesquita H. B., Feskens E. J., and Kromhout D., Dietary catechins and epithelial cancer incidence: the Zutphen elderly study, Int. J. Cancer, 2001; 92:298-302.
92. Le Marchand L., Murphy S. P., Hankin J. H., Wilkens L. R., and Kolonel L. N., Intake of flavonoids and lung cancer, J. Natl. Cancer Inst., 2000; 92:154-160.
93. Mettlin C., Milk drinking, other beverage habits, and lung cancer risk, Int. J. Cancer, 1989; 43:608-612.
94. Tewes F. J., Koo L. C., Meisgen T. J., and Rylander R., Lung cancer risk and mutagenicity of tea, Environ. Res., 1990; 52:23-33.
95. Huang C., Zhang X., Qiao Z., et al., A case control study of dietary factors in patients with lung cancer, Biomed. Environ. Sci. 1992; 5:257-265.
96. Koo L. C., Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked, Nutr. Cancer, 1988; 11:155-172.
97. Ohno Y., Wakai K., Genka K., et al., Tea consumption and lung cancer risk: a case control study in Okinawa, Japan, Jpn. J. Cancer Res., 1995; 86:1027-1034.
98. Mendilaharsu M., De Stefani E., Deneo-Pellegrini H., Carzoglio J. C., and Ronco A., Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case control study in Uruguay, Lung Cancer, 1998; 19:101-107.
99. Michaud D. S., Spiegelman D., Clinton S. K., et al., Fluid intake and the risk of bladder cancer in men, N. Engl. J. Med., 1999; 340:1390-1397.
100. Nagano J., Kono S., Preston D. L., et al., Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors, Int. J. Cancer, 2000; 86:132-138.
101. Zeegers M. P., Dorant E., Goldbohm R. A., and van den Brandt P. A., Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study, Cancer Causes Control, 2001; 12:231-238.
102. Morgan R. W. and Jain M. G., Bladder cancer: smoking, beverages and artificial sweeteners, Can. Med. Assoc. J., 1974; 111:1067-1070.
103. Simon D., Yen S., and Cole P., Coffee drinking and cancer of the lower urinary tract, J. Natl. Cancer Inst., 1975; 54:587-591.
104. Miller C. T., Neutel C. I., Nair R. C., Marrett L. D., Last J. M., and Collins W. E., Relative importance of risk factors in bladder carcinogenesis, J. Chronic Dis., 1978; 31:51-56.
105. Howe G. R., Burch J. D., Miller A. B., et al., Tobacco use, occupation, coffee, various nutrients, and bladder cancer, J. Natl. Cancer Inst., 1980; 64:701-713.
106. Hartge P., Hoover R., West D. W., and Lyon J. L., Coffee drinking and risk of bladder cancer, J. Natl. Cancer Inst., 1983; 70:1021-1026.
107. Ohno Y., Aoki K., Obata K., and Morrison A. S., Case control study of urinary bladder cancer in metropolitan Nagoya, Natl. Cancer Inst. Monogr., 1985; 69:229-234.
108. Claude J., Kunze E., Frentzel-Beyme R., Paczkowski K., Schneider J., and Schubert H., Life-style and occupational risk factors in cancer of the lower urinary tract, Am. J. Epidemiol., 1986; 124:578-589.
109. Iscovich J., Castelletto R., Esteve J., et al., Tobacco smoking, occupational exposure and bladder cancer in Argentina, Int. J. Cancer, 1987; 40:734-740.
110. Risch H. A., Burch J. D., Miller A. B., Hill G. B., Steele R., and Howe G. R., Dietary factors and the incidence of cancer of the urinary bladder, Am. J. Epidemiol., 1988; 127:1179-1191.
111. Nomura A. M., Kolonel L. N., Hankin J. H., and Yoshizawa C. N., Dietary factors in cancer of the lower urinary tract, Int. J. Cancer, 1991; 48:199-205.
112. Clavel J., and Cordier S., Coffee consumption and bladder cancer risk, Int. J. Cancer, 1991; 47:207-212.
113. Kunze E., Chang-Claude J., and Frentzel-Beyme R., Life style and occupational risk factors for bladder cancer in Germany. A case control study, Cancer, 1992; 69:1776-1790.
114. D'Avanzo B., La Vecchia C., Franceschi S., Negri E., Talamini R., and Buttino I., Coffee consumption and bladder cancer risk, Eur. J. Cancer, 1992; 28A: 1480-1484.
115. Yu Y., Hu J., Wang P. P., et al., Risk factors for bladder cancer: a case control study in northeast China, Eur. J. Cancer Prev., 1997; 6:363-369.
116. Bianchi G. D., Cerhan J. R., Parker A. S., et al., Tea consumption and risk of bladder and kidney cancers in a population-based case control study, Am. J. Epidemiol., 2000; 151:377-383.
117. Bruemmer B., White E., Vaughan T. L., and Cheney C. L., Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington, Nutr. Cancer 1997; 29:163-168.
118. Jensen O. M., Wahrendorf J., Knudsen J. B., and Sorensen B. L., The Copenhagen case control study of bladder cancer. II. Effect of coffee and other beverages, Int. J. Cancer, 1986; 37:651-657.
119. Slattery M. L., West D. W., and Robison L. M., Fluid intake and bladder cancer in Utah, Int. J. Cancer, 1988; 42:17-22.
120. Lu C. M., Lan S. J., Lee Y. H., Huang J. K., Huang C. H., and Hsieh C. C., Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan, Urology, 1999; 54:823-828.
121. Zeegers M. P., Tan F. E., Goldbohm R. A., and van den Brandt P. A., Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis, Int. J. Epidemiol., 2001; 30:353-362.
122. Ellison L. F., Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study, Eur. J. Cancer Prev., 2000; 9:125-130.
123. Jain M. G., Hislop G. T., Howe G. R., Burch J. D., and Ghadirian P., Alcohol and other beverage use and prostate cancer risk among Canadian men, Int. J. Cancer, 1998; 78:707-711.
124. Slattery M. L. and West D. W., Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States), Cancer Causes Control, 1993; 4:559-563.
125. Hunter D. J., Manson J. E., Stampfer M. J., et al., A prospective study of caffeine, coffee, tea and breast cancer (abstract), Am. J. Epidemiol., 1992; 136:1000-1001.
126. Lubin F., Ron E., Wax Y., and Modan B., Coffee and methylxanthines and breast cancer: a case control study, J. Natl. Cancer Inst., 1985; 74:569-573.
127. Schairer C., Brinton L. A., and Hoover R. N., Methylxanthines and breast cancer, Int. J. Cancer, 1987; 40:469-473.
128. Ewertz M. and Gill C., Dietary factors and breast cancer risk in Denmark, Int. J. Cancer, 1990; 46:779-784.
129. Tavani A., Pregnolato A., La Vecchia C., Favero A., and Franceschi S., Coffee consumption and the risk of breast cancer, Eur. J. Cancer Prev., 1998; 7:77-82.
130. Rosenblatt K. A., Thomas D. B., Jimenez L. M., et al., The relationship between diet and breast cancer in men (United States), Cancer Causes Control, 1999; 10:107-113.
131. Inoue M., Tajima K., Mizutani M., et al., Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan, Cancer Lett., 2001; 167:175-182.
132. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., and Higashi Y., Influence of drinking green tea on breast cancer malignancy among Japanese patients, Jpn. J. Cancer Res., 1998; 89:254-261.
133. Yang C. S., Chung J. Y., Yang G. Y., Li C., Meng X., and Lee M. J., Mechanisms of inhibition of carcinogenesis by tea, Biofactors, 2000; 13:73-79.
134. Hakim I. A., Harris R. B., and Weisgerber U. M., Tea intake and squamous cell carcinoma of the skin: influence of type of tea beverages, Cancer Epidemiol. Biomarkers Prev., 2000; 9:727-731.
135. Chan D. K., Woo J., Ho S. C., et al., Genetic and environmental risk factors for Parkinson's disease in a Chinese population, J. Neurol. Neurosurg. Psychiatry, 1998; 65:781-784.
136. Preux P. M., Condet A., Anglade C., et al., Parkinson's disease and environmental factors. Matched case control study in the Limousin region, France, Neuroepidemiology, 2000; 19:333-337.
137. Morano A., Jimenez-Jimenez F. J., Molina J. A., and Antolin M. A., Risk-factors for Parkinson's disease: case control study in the province of Caceres, Spain, Acta. Neurol. Scand., 1994; 89:164-170.
138. Kalmijn S., Feskens E. J., Launer L. J., and Kromhout D., Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men, Am. J. Epidemiol., 1997; 145:33-41.
139. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., and Dartigues J. F., Intake of flavonoids and risk of dementia, Eur. J. Epidemiol., 2000; 16:357-363.
140. Hegarty V. M., May H. M., and Khaw K. T., Tea drinking and bone mineral density in older women, Am. J. Clin. Nutr., 2000; 71:1003-1007.
141. Hernandez-Avila M., Stampfer M. J., Ravnikar V. A., et al., Caffeine and other predictors of bone density among pre- and perimenopausal women, Epidemiology, 1993; 4:128-134.
142. Johnell O., Gullberg B., Kanis J. A., et al., Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study, J. Bone Miner. Res., 1995; 10:1802-1815.
143. Kanis J., Johnell O., Gullberg B., et al., Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study, Osteoporos Int., 1999; 9:45-54.
144. Hernandez-Avila M., Colditz G. A., Stampfer M. J., Rosner B., Speizer F. E., and Willett W. C., Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women, Am. J. Clin. Nutr., 1991; 54:157-163.
145. Krall E. A., and Dawson-Hughes B., Osteoporosis. In: Shils M., Ed. Nutrition in Health and Disease, 9th ed., Baltimore: Williams & Wilkins, 1999:1353-1364.
146. Basu S., Michaelsson K., Olofsson H., Johansson S., and Melhus H., Association between oxidative stress and bone mineral density, Biochem. Biophys. Res. Commun., 2001; 288:275-279.
147. Trevisanato S. I. and Kim Y. I., Tea and health, Nutr. Rev. 2000; 58:1-10.
148. Rasheed A. and Haider M., Antibacterial activity of Camellia sinensis extracts against dental caries, Arch. Pharm. Res., 1998; 21:348-352.
149. Matsumoto M., Minami T., Sasaki H., Sobue S., Hamada S., and Ooshima T., Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci, Caries Res., 1999; 33:441-445.
150. Jones C., Woods K., Whittle G., Worthington H., and Taylor G., Sugar, drinks, deprivation and dental caries in 14-year-old children in the north west of England in 1995, Community Dent. Health, 1999; 16:68-71.
151. Curhan G. C., Willett W. C., Speizer F. E., and Stampfer M. J., Beverage use and risk for kidney stones in women, Ann. Intern. Med., 1998; 128:534-540.
152. Curhan G. C., Willett W. C., Rimm E. B., Spiegelman D., and Stampfer M. J., Prospective study of beverage use and the risk of kidney stones, Am. J. Epidemiol., 1996; 143:240-247.
153. Borghi L., Meschi T., Schianchi T., et al., Urine volume: stone risk factor and preventive measure, Nephron, 1999; 81 Suppl 1:31-37.
154. Massey L. K., Roman-Smith H., and Sutton R. A., Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones, J. Am. Diet. Assoc., 1993; 93:901-906.
155. Massey L. K., Tea oxalate, Nutr. Rev, 2000; 58:88-89.
156. Balentine D. A. and Paetau-Robinson I., Tea as a source of dietary antioxidants with a potential role in prevention of chronic diseases. In: Mazza G. and Oomah B. D., Eds. Herbs, Botanicals, & Teas. Lancaster: Technomic Publishing Co., Inc., 2000:265-287.
157. Lakenbrink C., Lapczynski S., Maiwald B., and Engelhardt U. H., Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages, J. Agric. Food Chem., 2000; 48:2848-2852.
158. Balentine D. A., Wiseman S. A., and Bouwens L. C., The chemistry of tea flavonoids, Crit. Rev. Food Sci. Nutr., 1997; 37:693-704.
159. Okushio K., Matsumoto N., Kohri T., Suzuki M., Nanjo F., and Hara Y., Absorption of tea catechins into rat portal vein, Biol. Pharm. Bull., 1996; 19:326-329.
160. Kim S., Lee M. J., Hong J., et al., Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols, Nutr. Cancer, 2000; 37:41-48.
161. Yang C. S., Chen L., Lee M. J., Balentine D., Kuo M. C., and Schantz S. P., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidemiol. Biomarkers. Prev., 1998; 7:351-354.
162. van het Hof K. H., Kivits G. A., Weststrate J. A., and Tijburg L. B., Bioavailability of catechins from tea: the effect of milk, Eur. J. Clin. Nutr., 1998; 52:356-359.
163. Chow H. H., Cai Y., Alberts D. S., et al., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, Cancer Epidemiol. Biomarkers. Prev., 2001; 10:53-58.
164. Van Amelsvoort J. M., Van Hof K. H., Mathot J. N., Mulder T. P., Wiersma A., and Tijburg L. B., Plasma concentrations of individual tea catechins after a single oral dose in humans, Xenobiotica, 2001; 31:891-901.
165. Chen L., Lee M. J., Li H., and Yang C. S., Absorption, distribution, elimination of tea polyphenols in rats, Drug Metab. Dispos., 1997; 25:1045-1050.
166. Lee M. J., Wang Z. Y., Li H., et al., Analysis of plasma and urinary tea polyphenols in human subjects, Cancer Epidemiol. Biomarkers. Prev., 1995; 4:393-399.
167. Kohri T., Matsumoto N., Yamakawa M., et al., Metabolic fate of (-)-[4-(3)H]epigallocatechin gallate in rats after oral administration, J. Agric. Food Chem., 2001; 49:4102-4112.
168. Li C., Lee M. J., Sheng S., et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion, Chem. Res. Toxicol., 2000; 13:177-184.
169. Yang C. S., Lee M. J., and Chen L., Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies, Cancer Epidemiol. Biomarkers. Prev., 1999; 8:83-89.
170. Hollman P. C., Tijburg L. B., and Yang C. S., Biovailability of flavonoids from tea, Crit. Rev. Food Sci. Nutr., 1997; 37:719-738.
171. Piskula M. K., and Terao J., Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues, J. Nutr., 1998; 128:1172-1178.
172. Kuhnle G., Spencer J. P., Schroeter H., et al., Epicatechin and catechin are O-methylated and glucuronidated in the small intestine, Biochem. Biophys. Res. Commun., 2000; 277:507-512.
173. Donovan J. L., Bell J. R., Kasim-Karakas S., et al., Catechin is present as metabolites in human plasma after consumption of red wine, J. Nutr., 1999; 129:1662-1668.
174. Scalbert A. and Williamson G., Dietary intake and bioavailability of polyphenols, J. Nutr., 2000; 130:2073S-2085S.
175. Da Silva E. L., Piskula M., and Terao J., Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin, Free Radic. Biol. Med., 1998; 24:1209-1216.
176. Pietta P. G., Simonetti P., Gardana C., Brusamolino A., Morazzoni P., and Bombardelli E., Catechin metabolites after intake of green tea infusions, Biofactors, 1998; 8:111-118.
177. Pietta P., Simonetti P., Gardana C., and Mauri P., Trolox equivalent antioxidant capacity (TEAC) of Ginkgo biloba flavonol and Camellia sinensis catechin metabolites, J. P harm. Biomed. Anal., 2000; 23:223-226.
178. Nanjo F., Mori M., Goto K., and Hara Y., Radical scavenging activity of tea catechins and their related compounds, Biosci. Biotechnol. Biochem., 1999; 63:1621-1623.
179. Harada M., Kan Y., Naoki H., et al., Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin, Biosci. Biotechnol. Biochem., 1999; 63:973-977.
180. Kida K., Suzuki M., Matsumoto N., Nanjo F., and Hara Y., Identification of biliary metabolites of (-)-epigallocatechin gallate in rats, J. Agric. Food Chem., 2000; 48:4151-4155.
181. Koga T., and Meydani M., Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells, Am. J. Clin. Nutr., 2001; 73:941-948.
182. Spencer J. P., Schroeter H., Kuhnle G., et al., Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involvhig caspase-3 activation, Biochem. J., 2001; 354:493-500.
183. Schroeter H., Spencer J. P., Rice-Evans C., and Williams R. J., Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3, Biochem. J., 2001; 358:547-557.
184. Spencer J. P., Schroeter H., Crossthwaithe A. J., Kuhnle G., Williams R. J., and Rice-Evans C., Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts, Free Radic. Biol. Med., 2001; 31:1139-1146.
185. Rice-Evans C., Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans, Proc. Soc. Exp. Biol. Med., 1999; 220:262-266.
186. Halliwell B. and Gutteridge J. M. C., Free Radicals in Biology and Medicine, 3rd ed., New York: Oxford University Press, 1999.
187. Jovanavic S. V., Steenken S., and Simic M. G., Reduction potentials of flavonoid and model phenoxyl radicals, J. Chem. Soc. Perkins Trans., 1996; 2:2497-2503.
188. Bors W., and Michel C., Antioxidant capacity of flavanols and gallate esters: pulse radiolysis studies, Free Radic. Biol. Med., 1999; 27:1413-1426.
189. Guo Q., Zhao B., Shen S., Hou J., Hu J., and Xin W., ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers, Biochim. Biophys. Acta, 1999; 1427:13-23.
190. Zhao B., Guo Q., and Xin W., Free radical scavenging by green tea polyphenols, Methods Enzymol., 2001; 335:217-231.
191. Rice-Evans C. A., Miller N. J., and G. P., Antioxidant properties of phenolic compounds, Trends Plant Sci., 1997; 2:152-159.
192. Nanjo F., Goto K., Seto R., Suzuki M., Sakai M., and Hara Y., Scavenging effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical, Free Radic. Biol. Med., 1996; 21:895-902.
193. Haenen G. R. and Bast A., Nitric oxide radical scavenging of flavonoids, Methods Enzymol., 1999; 301:490-503.
194. Paquay J. B., Haenen G. R., Slender G., Wiseman S. A., Tijburg L. B., and Bast A., Protection against nitric oxide toxicity by tea, J. Agric. Food Chem., 2000; 48:5768-5772.
195. Pannala A. S., Rice-Evans C. A., Halliwell B., and Singh S., Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols, Biochem. Biophys. Res. Commun., 1997; 232:164-168.
196. Fiala E. S., Sodum R. S., Bhattacharya M., and Li H., (-)-Epigallocatechin gallate, apolyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine, Experientia, 1996; 52:922-926.
197. Rice-Evans C. A., Miller N. J., and Paganga G., Structure-antioxidant activity relationships of flavonoids and phenolic acids, Free Radic. Biol. Med., 1996; 20:933-956.
198. Valcic S., Muders A., Jacobsen N. E., Liebler D. C., and Timmermann B. N., Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals, Chem. Res. Toxicol., 1999; 12:382-386.
199. Valcic S., Burr J. A., Timmermann B. N., and Liebler D. C., Antioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals, Chem. Res. Toxicol., 2000; 13:801-810.
200. Zhu N., Huang T. C., Yu Y., LaVoie E. J., Yang C. S., and Ho C. T., Identification of oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin with H(2)O(2), J. Agric. Food Chem., 2000; 48:979-981.
201. Kondo K., Kurihara M., and Fukuhara K., Mechanism of antioxidant effect of catechins, Methods Enzymol., 2001; 335:203-217.
202. Salah N., Miller N. J., Paganga G., Tijburg L., Bolwell G. P., and Rice-Evans C., Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants, Arch. Biochem. Biophys., 1995; 322:339-346.
203. Hider R. C., Liu Z. D., and Khodr H. H., Metal chelation of polyphenols, Methods Enzymol., 2001; 335:190-203.
204. Kumamoto M., Sonda T., Nagayama K., and Tabata M., Effects of pH and metal ions on antioxidative activities of catechins, Biosci. Biotechnol. Biochem., 2001; 65:126-132.
205. Brown J. E., Khodr H., Hider R. C., and Rice-Evans C. A., Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties, Biochem. J., 1998; 330:1173-1178.
206. Pan M. H., Lin-Shiau S. Y., Ho C. T., Lin J. H., and Lin J. K., Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages, Biochem. Pharmacol., 2000; 59:357-367.
207. Nomura M., Ma W., Chen N., Bode A. M., and Dong Z., Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins, Carcinogenesis, 2000; 21:1885-1890.
208. Yang F., Oz H. S., Barve S., de Villiers W. J., McClain C. J., and Varilek G. W., The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6, Mol. Pharmacol., 2001; 60:528-533.
209. Nam S., Smith D. M., and Dou Q. P., Ester bond-containing teapolyphenols potently inhibit proteasome activity in vitro and in vivo, J. Biol. Chem., 2001; 276:13322-13330.
210. Nomura M., Ma W. Y., Huang C., et al., Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea, Mol. Carcinog., 2000; 28:148-155.
211. Chung J. Y., Huang C., Meng X., Dong Z., and Yang C. S., Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved, Cancer Res., 1999; 59:4610-4617.
212. Dong Z., Ma W., Huang C., and Yang C. S., Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins, Cancer Res., 1997; 57:4414-4419.
213. Barthelman M., Bair W. B., 3rd, Stickland K. K., et al., (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity, Carcinogenesis, 1998; 19:2201-2204.
214. Katiyar S. K., Afaq P., Azizuddin K., and Mukhtar H., Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatecnin-3-gallate, Toxicol. Appl. Pharmacol., 2001; 176:110-117.
215. Surh Y. J., Chun K. S., Cha H. H., et al., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation, Mutat. Res., 2001; 480-481:243-268.
216. Chan M. M., Pong D., Ho C. T., and Huang H. I., Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea, Biochem. Pharmacol., 1997; 54:1281-1286.
217. Lin Y. L. and Lin J. K., (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB, Mol. Pharmacol., 1997; 52:4605-72.
218. Lin Y. L., Tsai S. H., Lin-Shiau S. Y., Ho C. T., and Lin J. K., Theaflavin-3,3′-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages, Eur. J. Pharmacol., 1999; 367:379-388.
219. Sarkar A. and Bhaduri A., Black tea is a powerful chemopreventor of reactive oxygen and nitrogen species: comparison with its individual catechin constituents and green tea, Biochem. Biophys. Res. Commun., 2001; 284:173-178.
220. Parkinson A., Biotransformation of xenobiotics. In: Klassen C. D., Ed. Cassarett and Doull's Toxicology: The Basic Science of Poisons, 5th ed., New York: McGraw-Hill, 1996:113-186.
221. Laughton M. J., Evans P. J., Moroney M. A., Hoult J. R., and Halliwell B., Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability, Biochem. Pharmacol., 1991; 42:1673-1681.
222. da Silva E. L., Abdalla D. S., and Terao J., Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase, I.U.M.B. Life, 2000; 49:289-295.
223. Ikawa H., Kamitani H., Calvo B. F., Foley J. F., and Eling T. E., Expression of 15-lipoxygenase-1 in human colorectal cancer, Cancer Res., 1999; 59:360-366.
224. Hong J., Smith T. J., Ho C. T., August D. A., and Yang C. S., Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues, Biochem. Pharmacol., 2001; 62:1175-1183.
225. Katiyar S. K. and Mukhtar H., Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols, Carcinogenesis, 1997; 18:1911-1916.
226. Katiyar S. K., Agarwal R., Wood G. S., and Mukhtar H., Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz-[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea, Cancer Res., 1992; 52:6890-6897.
227. Agarwal R., Katiyar S. K., Khan S. G., and Mukhtar H., Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea, Photochem. Photobiol., 1993; 58:695-700.
228. Metz N., Lobstein A., Schneider Y., et al., Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract, Nutr. Cancer, 2000; 38:60-64.
229. Aucamp J., Gaspar A., Hara Y., and Apostolides Z., Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis), Anticancer Res., 1997; 17:4381-4385.
230. Lin J. K., Chen P. C., Ho C. T., and Lin-Shiau S. Y., Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3′-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate, J. Agric. Food Chem., 2000; 48:2736-2743.
231. Abraham S. K., Singh S. P., and Kesavan P. C., In vivo antigenotoxic effects of dietary agents and beverages co-administered with urethane: assessment of the role of glutathione S-transferase activity, Mutat. Res., 1998; 413:103-110.
232. Khan S. G., Katiyar S. K., Agarwal R., and Mukhtar H., Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention, Cancer Res., 1992; 52:4050-4052.
233. Lin Y.-L., Cheng C.-Y., Lin Y.-P., Lau Y.-W., Juan I.-M., and Lin J.-K., Hypolipidemic effect of green tea leaves through induction of antioxidant and phase II enzymes including superoxide dismutase, catalase, and glutathione-S-transferase in rats, J. Agric. Food Chem., 1998; 46:1893-1899.
234. Chou F. P., Chu Y. C., Hsu J. D., Chiang H. C., and Wang C. J., Specific induction of glutathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in rat liver, Biochem. Pharmacol., 2000; 60:643-650.
235. Wasserman W. W. and Fahl W. E., Functional antioxidant responsive elements, Proc. Natl. Acad. Sci. U.S.A., 1997; 94:5361-5366.
236. Yu R., Jiao J. J., Duh J. L., Gudehithlu K., Tan T. H., and Kong A. N., Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression, Carcinogenesis, 1997; 18:451-456.
237. Chen C., Yu R., Owuor E. D., and Kong A. N., Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death, Arch. Pharm. Res., 2000; 23:605-612.
238. Nagasawa T., Hayashi H., Fujimaki N., Nishizawa N., and Kitts D. D., Induction of oxidatively modified proteins in skeletal muscle by electrical stimulation and its suppression by dietary supplementation of (-)-epigallocatechin gallate, Biosci. Biotechnol. Biochem., 2000; 64:1004-1010.
239. Katiyar S. K., Afaq F., Perez A., and Mukhtar H., Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress, Carcinogenesis, 2001; 22:287-294.
240. van het Hof K. H., de Boer H. S., Wiseman S. A., Lien N., Westrate J. A., and Tijburg L. B., Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans, Am. J. Clin. Nutr., 1997; 66:1125-1132.
241. Freese R., Basu S., Hietanen E., et al., Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females, Eur. J. Nutr., 1999; 38:149-157.
242. Rice-Evans C. A., Measurement of total antioxidant activity as a marker of antioxidant status in vivo: procedures and limitations, Free Radic. Res., 2000; 33:859-66.
243. Serafini M., Ghiselli A., and Ferro-Luzzi A., In vivo antioxidant effect of green and black tea in man, Eur. J. Clin. Nutr., 1996; 50:28-32.
244. Serafini M., Laranjinha J. A., Almeida L. M., and Maiani G., Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on plasma total antioxidant capacity in humans, J. Nutr. Biochem., 2000; 11:585-590.
245. Langley-Evans S. C., Consumption of black tea elicits an increase in plasma antioxidant potential in humans, Int. J. Food Sci. Nutr., 2000; 51:309-315.
246. Pietta P., Simonetti P., Gardana C., Brusamolino A., Morazzoni P., and Bombardelli E., Relationship between rate and extent of catechin absorption and plasma antioxidant status, Biochem. Mol. Biol. Int., 1998; 46:895-903.
247. Benzie I. F., Szeto Y. T., Strain J. J., and Tomlinson B., Consumption of green tea causes rapid increase in plasma antioxidant power in humans, Nutr. Cancer, 1999; 34:83-87.
248. Sung H., Nah J., Chun S., Park H., Yang S. E., and Min W. K., In vivo antioxidant effect of green tea, Eur. J. Clin. Nutr., 2000; 54:527-529.
249. Hodgson J. M., Puddey I. B., Croft K. D., et al., Acute effects of ingestion of black and green tea on lipoprotein oxidation, Am. J. Clin. Nutr., 2000; 71:1103-1107.
250. Leenen R., Roodenburg A. J., Tijburg L. B., and Wiseman S. A., A single dose of tea with or without milk increases plasma antioxidant activity in humans, Eur. J. Clin. Nutr., 2000; 54:87-92.
251. Maxwell S. and Thorpe G., Tea flavonoids have little short term impact on serum antioxidant activity, Br. Med. J., 1996; 313:229.
252. McAnlis G. T., McEneny J., Pearce J., and Young I. S., Black tea consumption does not protect low density lipoprotein from oxidative modification, Eur. J. Clin. Nutr., 1998; 52:202-206.
253. Arts M. J., Haenen G. R., Voss H. P., and Bast A., Masking of antioxidant capacity by the interaction of flavonoids with protein, Food Chem. Toxicol., 2001; 39:787-791.
254. Cherabini A., Beal M. F., and Frei B., Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo, Free Radic. Biol. Med., 1999; 27:381-387.
255. Nakagawa K., Ninomiya M., Okubo T., et al., Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans, J. Agric. Food Chem., 1999; 47:3967-3973.
256. Miura Y., Chiba T., Miura S., et al., Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low-density lipoproteins: an ex vivo study in humans, J. Nutr. Biochem., 2000; 11:216-222.
257. Princen H. M., van Duyvenvoorde W., Buytenhek R., et al., No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers, Arterioscler. Thromb. Vasc. Biol., 1998; 18:833-841.
258. Lean M. E., Noroozi M., Kelly I., et al., Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA, Diabetes, 1999; 48:176-181.
259. Tijburg L. B., Wiseman S. A., Meijer G. W., and Weststrate J. A., Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits, Atherosclerosis, 1997; 135:37-47.
260. Vinson J. A. and Dabbagh Y. A., Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking, F.E.B.S. Lett., 1998; 433:44-46.
261. Anderson J. W., Diwadkar V. A., and Bridges S. R., Selective effects of different antioxidants on oxidation of lipoproteins from rats, Proc. Soc. Exp. Biol. Med., 1998; 218:376-381.
262. Crawford R. S., Kirk E. A., Rosenfeld M. E., LeBoeuf R. C., and Chait A., Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse, Arterioscler. Thromb. Vasc. Biol., 1998; 18:1506-1513.
263. Ishikawa T., Suzukawa M., Ito T., et al., Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification, Am. J. Clin. Nutr., 1997; 66:261-266.
264. Yokozawa T. and Dong E., Influence of green tea and its three major components upon low-density lipoprotein oxidation, Exp. Toxicol. Pathol., 1997; 49:329-335.
265. Liu Z., Ma L. P., Zhou B., Yang L., and Liu Z. L., Antioxidative effects of green tea polyphenols on free radical initiated and photosensitized peroxidation of human low density lipoprotein, Chem. Phys. Lipids, 2000; 106:53-63.
266. Yang T. T., and Koo M. W., Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation, Atherosclerosis, 2000; 148:67-73.
267. Zhu Q. Y., Huang Y., Tsang D., and Chen Z. Y., Regeneration of alpha-tocopherol in human low-density lipoprotein by green tea catechin, J. Agric. Food Chem., 1999; 47:2020-2025.
268. Lotito S. B. and Fraga C. G., Catechins delay lipid oxidation and alpha-tocopherol and beta-carotene depletion following ascorbate depletion in human plasma, Proc. Soc. Exp. Biol. Med., 2000; 225:32-38.
269. Nanjo F., Honda M., Okushio K., et al., Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets, Biol. Pharm. Bull., 1993; 16:1156-1159.
270. Miura Y., Chiba T., Tomita I., et al., Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice, J. Nutr., 2001; 131:27-32.
271. Kim J., Hwang J. S., Cho Y. K., Han Y., Jeon Y. J., and Yang K. H., Protective effects of (-)-epigallocatechin-3-gallate on UVA- and UVB-induced skin damage, Skin Pharmacol. Appl. Skin Physiol., 2001; 14:11-19.
272. Janero D. R., Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med., 1990; 9:515-540.
273. Hayek T., Fuhrman B., Vaya J., et al., Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation, Arterioscler. Thromb. Vasc. Biol., 1997; 17:2744-2752.
274. Morrow J. D., Chen Y., Brame C. J., et al., The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation, Drug Metab. Rev., 1999; 31:117-139.
275. Hodgson J. M., Croft K. D., Mori T. A., Burke V., Beilin L. J., and Puddey I. B., Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans, J. Nutr., 2002; 132:55-58.
276. O'Reilly J. D., Mallet A. I., McAnlis G. T., et al., Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans, Am. J. Clin. Nutr., 2001; 73:1040-1044.
277. Yang C. S., Chung J. Y., Yang G., Chhabra S. K., and Lee M. J., Tea and tea polyphenols in cancer prevention, J. Nutr., 2000; 130:4728-4785.
278. Xu Y., Ho C. T., Amin S. G., Han C., and Chung F. L., Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants, Cancer Res., 1992; 52:3875-3879.
279. Inagake M., Yamane T., Kitao Y., et al., Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage by green tea extract in rat, Jpn. J. Cancer Res., 1995; 86:1106-1111.
280. Lodovici M., Casalini C., De Filippo C., et al., Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage in rat colon mucosa by black tea complex polyphenols, Food Chem. Toxicol., 2000; 38:1085-1088.
281. Hasegawa R., Chujo T., Sai-Kato K., Umemura T., Tanimura A., and Kurokawa Y., Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane, Food Chem. Toxicol., 1995; 33:961-970.
282. Sai K., Kai S., Umemura T., et al., Protective effects of green tea on hepatotoxicity, oxidative DNA damage and cell proliferation in the rat liver induced by repeated oral administration of 2-nitropropane, Food Chem. Toxicol., 1998; 36:1043-1051.
283. Takabayashi F., Harada N., Tahara S., Kaneko T., and Hara Y., Effect of green tea catechins on the amount of 8-hydroxydeoxyguanosine (8-OHdG) in pancreatic and hepatic DNA after a single administration of N-nitrosobis(2- oxopropyl)amine (BOP), Pancreas, 1997; 15:109-112.
284. Xue K. X., Wang S., Ma G. J., et al., Micronucleus formation in peripheral-blood lymphocytes from smokers and the influence of alcohol- and tea-drinking habits, Int. J. Cancer, 1992; 50:702-705.
285. Li N., Sun Z., Han C., and Chen J., The chemopreventive effects of tea on human oral precancerous mucosa lesions, Proc. Soc. Exp. Biol. Med., 1999; 220:218-224.
286. Klaunig J. E., Xu Y., Han C., et al., The effect of tea consumption on oxidative stress in smokers and nonsmokers, Proc. Soc. Exp. Biol. Med., 1999; 220:249-254.
287. Katiyar S. K., Perez A., and Mukhtar H., Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA, Clin. Cancer Res., 2000; 6:3864-3869.
288. McKay D. L. and Blumberg J. B., The role of tea in human health: an update, J. Am. Coll. Nutr., 2002; 21:1-13.
289. Anderson R. F., Fisher L. J., Hara Y., et al., Green tea catechins partially protect DNA from (.)OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals, Carcinogenesis, 2001; 22:1189-1193.
290. Jovanavic S. V., Hara Y., Steenken S., and Simic M. G., Antioxidant potential of gallocatechins. A pulse radiolysis laser photolysis study, J. Am. Chem. Soc., 1995; 117:9881-9888.
291. Yamaguchi Y., Hayashi M., Yamazoe H., and Kunitomo M., [Preventive effects of green tea extract on lipid abnormalities in serum, liver and aorta of mice fed a atherogenic diet], Nippon Yakurigaku Zasshi, 1991; 97:329-337.
292. Osada K., Takahashi M., Hoshina S., Nakamura M., Nakamura S., and Sugano M., Tea catechins inhibit cholesterol oxidation accompanying oxidation of low-density lipoprotein in vitro, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2001; 128:153-164.
293. Uchida S., Ozaki M., Suzuki K., and Shikita M., Radio-protective effects of (-)-epigallocatechin 3-O-gallate (green-tea tannin) in mice, Life Sci., 1992; 50:147-152.
294. Sano M., Takahashi Y., Yoshino K., et al., Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding, Biol. Pharm. Bull., 1995; 18:1006-1008.
295. Lin A. M., Chyi B. Y., Wu L. Y., Hwang L. S., and Ho L. T., The antioxidative property of green tea against iron-induced oxidative stress in rat brain, Chin. J. Physiol., 1998; 41:189-194.
296. Matsumoto H., Yamane T., Inagake M., et al., Inhibition of mucosal lipid hyperoxidation by green tea extract in 1,2-dimethylhydrazine-induced rat colonic carcinogenesis, Cancer Lett., 1996; 104:205-209.
297. Inanami O., Watanabe Y., Syuto B., Nakano M., Tsuji M., and Kuwabara M., Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil, Free Radic. Res., 1998; 29:359-365.
298. Lee S., Suh S., and Kim S., Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils, Neurosci. Lett., 2000; 287:191-194.
299. Hong J. T., Ryu S. R., Kim H. J., et al., Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury, Brain Res. Bull., 2000; 53:743-749.
300. Hong J. T., Ryu S. R., Kim H. J., et al., Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils, Brain Res., 2001; 888:11-18.
301. van het Hof K. H., Wiseman S. A., Yang C. S., and Tijburg L. B., Plasma and lipoprotein levels of tea catechins following repeated tea consumption, Proc. Soc. Exp. Biol. Med., 1999; 220:203-209.